Rapid and Efficient Directed Differentiation of Human Pluripotent Stem Cells Into Retinal Pigmented Epithelium
Abstract
Controlling the differentiation of human pluripotent stem cells is the goal of many laboratories, both to study normal human development and to generate cells for transplantation. One important cell type under investigation is the retinal pigmented epithelium (RPE). Age-related macular degeneration (AMD), the leading cause of blindness in the Western world, is caused by dysfunction and death of the RPE. Currently, RPE derived from human embryonic stem cells are in clinical trials for the treatment of AMD. Although protocols to generate RPE from human pluripotent stem cells have become more efficient since the first report in 2004, they are still time-consuming and relatively inefficient. We have found that the addition of defined factors at specific times leads to conversion of approximately 80% of the cells to an RPE phenotype in only 14 days. This protocol should be useful for rapidly generating RPE for transplantation as well as for studying RPE development in vitro.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Apr 18, 2013
- Source ID
- 10.5966/sctm.2012-0163
Entities
People
- Britney O. Pennington
- Cassidy R. Hinman
- David E Buchholz
- Dennis O. Clegg
- Peter J. Coffey
- Roxanne H. Croze
Organizations
- California Institute for Regenerative Medicine
- The Institute for Collaborative Biotechnologies
- University of California
- University of California, Santa Barbara